Last updated 19 October 2018
We commit to ensuring the quality, safety and reliable supply of our products. If the supply of our medicines or vaccines is disrupted in Australia we will publish details here.
Menveo [Meningococcal (Groups A, C, W-135 and Y) Oligosaccharide CRM197 Conjugate Vaccine] is experiencing a supply constraint and is currently out of stock.
This supply constraint is due to manufacturing disruption combined with high demand. There is no impact on the safety or quality of the product. We expect the supply situation to normalise in 2019, and will provide the next update on supply of this vaccine in January 2019.
Havrix 1440 Adult [inactivated hepatitis A virus vaccine] is experiencing an intermittent supply constraint, however limited doses are available in the marketk. We expect to provide the next update in January 2019.
Please note, that the following GSK hepatitis A containing vaccines continue to be in stock and are not impacted by this supply constraint: Twinrix Adult [720/20] [combined hepatitis A and hepatitis B vaccine], Twinrix Junior [360/10] [combined hepatitis A and hepatitis B vaccine].
Please visit the TGA website for ongoing updates to supply.
For more information on GSK's medicines or vaccines, please contact GSK medical information on 1800 033 109.